Bristlecone Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,117	Closed	-$223K	–	292
2024 Q1	$223K	Sell	4,117 -270	-6%	-$13.8K	0.02%	265
2023 Q4	$225K	Sell	4,387 -490	-10%	-$25.7K	0.02%	253
2023 Q3	$283K	Buy	4,877 +8	+0.2%	+$490	0.03%	216
2023 Q2	$311K	Buy	4,869 +287	+6%	+$19.2K	0.03%	215
2023 Q1	$318K	Buy	4,582 +506	+12%	+$35.7K	0.03%	214
2022 Q4	$293K	Buy	4,076 +6	+0.1%	+$452	0.04%	210
2022 Q3	$289K	Sell	4,070 -53	-1%	-$3.85K	0.04%	201
2022 Q2	$317K	Buy	4,123 +6	+0.1%	+$457	0.04%	198
2022 Q1	$301K	Sell	4,117 -220	-5%	-$14.8K	0.04%	197
2021 Q4	$270K	Buy	4,337 +7	+0.2%	+$411	0.03%	198
2021 Q3	$256K	Buy	4,330 +800	+23%	+$52.7K	0.03%	192
2021 Q2	$236K	Buy	3,530 +45	+1%	+$2.93K	0.03%	198
2021 Q1	$220K	Buy	+3,485	New	+$217K	0.03%	198
2020 Q1	–	Sell	-9,141	Closed	-$587K	–	158
2019 Q4	$587K	Buy	+9,141	New	+$524K	0.12%	126
2019 Q3	–	Sell	-5,424	Closed	-$246K	–	145
2019 Q2	$246K	Buy	+5,424	New	+$253K	0.06%	162
2016 Q2	–	Sell	-3,990	Closed	-$255K	–	140
2016 Q1	$255K	Buy	+3,990	New	+$252K	0.1%	144